Skip to main content
. 2015 Jan 28;6(3):302–307. doi: 10.1021/ml500494j

Figure 1.

Figure 1

(A) Structures of human neuromedin U-derived peptides 1a–d and the SAR results from our previous study.11 Arrows indicate the structural entities required for potent biological activity of the derivatives. (B) Structures of the NMUR1-selective agonist 2 and the NMUR2-selective agonist 3.11